StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)

Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%

Oramed Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Oramed Pharmaceuticals's gross margin for the twelve months ending Dec 31, 2025 was 0.7%. For fiscal 2025 it was 0.7%, against 96.7% the year before. The highest annual figure on record is 103.5% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20250.7%−96.0
FY2019Aug 31, 201996.7%−6.8
FY2018Aug 31, 2018103.5%+11.1
FY2017Aug 31, 201792.4%+68.8
FY2016Aug 31, 201623.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2025CQ1 2025Mar 31, 20250.7%−113.3
Q4 FY2019CQ3 2019Aug 31, 2019100.0%+0.0
Q3 FY2019CQ2 2019May 31, 2019100.0%+0.0
Q4 FY2018CQ3 2018Aug 31, 2018100.0%+0.0
Q3 FY2018CQ2 2018May 31, 2018113.9%+44.6
Q4 FY2017CQ3 2017Aug 31, 2017100.0%+54.0
Q3 FY2017CQ2 2017May 31, 2017100.0%+3.2
Q2 FY2017CQ1 2017Feb 28, 2017100.0%–
Q1 FY2017CQ4 2016Nov 30, 201669.3%–
Q4 FY2016CQ3 2016Aug 31, 201646.0%–
Q2 FY2016CQ1 2016Feb 29, 201696.8%–

More Oramed Pharmaceuticals figures

See a number that looks wrong?